by admin | Aug 30, 2024 | Aging, Dementia
Eric B. Larson, University of Washington and Laura Gitlin, Drexel University Nearly half of all dementia cases could be delayed or prevented altogether by addressing 14 possible risk factors, including vision loss and high cholesterol. That is the key finding of a new...
by admin | Aug 30, 2024 | Health, Mitochondria, Parkinson's Disease
Rebecca Zhangqiuzi Fan, Florida International University and Kim Tieu, Florida International University In 1817, a British physician named James Parkinson published An Essay on the Shaking Palsy, describing for the first time cases of a neurodegenerative disorder now...
by admin | Aug 30, 2024 | COVID-19, Immune Response, Virology
Dr. Philip McMillan, John McMillan In the complex world of immunology, the human body’s defense system can be likened to a sophisticated border control operation. Under normal circumstances, our immune system, like well-trained border agents, is adept at...
by John McMillan | Aug 23, 2024 | COVID-19, Health
Sheena Cruickshank, University of Manchester This summer has seen a large COVID wave – one which is showing potential to be bigger than the 2023 winter wave was. The current wave has largely been driven by the so-called FLiRT variants, which have acquired greater...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
Recent Comments